Vanguard Capital Management
VRCA icon

Vanguard Capital Management’s Verrica Pharmaceuticals VRCA Stock Holding History

Vanguard Capital Management’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.71M Buy
279,310
+90,552
+48% +$565K ﹤0.01% 3468
2026
Q1 		$999K Buy
+188,758
New +$1.21M ﹤0.01% 3551

Other funds holding VRCA

CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management's VRCA Position: Q2 2026 in Review

Vanguard Capital Management increased its Verrica Pharmaceuticals (VRCA) stake by 48% in Q2 2026, buying an estimated $565K and bringing the position to 279,310 shares worth $1.71M. The position accounts for ﹤0.01% of the portfolio, ranked #3468.

Vanguard Capital Management first reported a position in VRCA in Q1 2026 and has held it in 2 quarters since. 41 funds tracked by Wall St. Rank hold VRCA as of Q2 2026.

  • Vanguard Capital Management held 279,310 shares of Verrica Pharmaceuticals worth $1.71M as of Q2 2026.
  • Vanguard Capital Management bought 90,552 Verrica Pharmaceuticals shares in Q2 2026, an estimated $565K.
  • Verrica Pharmaceuticals made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3468 holding.
  • Vanguard Capital Management first reported a position in Verrica Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 41 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.